OKYO Pharma (OKYO) Other Non-Current Assets (2023 - 2025)
OKYO Pharma (OKYO) reported Other Non-Current Assets of $4500.0 for Q3 2025, little changed year-over-year from $4500.0 in Q3 2024, and little changed quarter-over-quarter from $4500.0 in Q1 2025.
OKYO Pharma (OKYO) Other Non-Current Assets (2023 - 2025) Analysis & Trends
OKYO Pharma (OKYO) has 3 years of Other Non-Current Assets data on file, last reported at $4500.0 in Q3 2025.
- Other Non-Current Assets for Q3 2025 came in at $4500.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $4500.0 (changed 0.0% YoY), and the FY2025 annual result was $4500.0, changed 0.0% from the prior year.
- Other Non-Current Assets held at $4500.0 in Q3 2025 per OKYO's latest filing, from $4500.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $4500.0 in Q3 2023 and troughed at $4500.0 in Q3 2023.
- A 3-year average of $4500.0 and a median of $4500.0 in 2023 frame the typical range for Other Non-Current Assets.
- On a YoY basis, Other Non-Current Assets climbed as much as 0.0% in 2024 and fell as far as 0.0% in 2024.
- A 3-year view of Other Non-Current Assets shows it stood at $4500.0 in 2023, then changed by 0.0% to $4500.0 in 2024, then changed by 0.0% to $4500.0 in 2025.
- Business Quant data shows OKYO's Other Non-Current Assets at $4500.0 in Q3 2025, $4500.0 in Q1 2025, and $4500.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | OKYO Pharma | 244.98 Mn | 240.76 Mn | - | 4,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4,500.00 |
| Mar 31, 2025 | 4,500.00 |
| Sep 30, 2024 | 4,500.00 |
| Mar 31, 2024 | 4,500.00 |
| Sep 30, 2023 | 4,500.00 |